Page last updated: 2024-10-24

carbazilquinone and Delayed Hypersensitivity

carbazilquinone has been researched along with Delayed Hypersensitivity in 2 studies

Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.

Research Excerpts

ExcerptRelevanceReference
"The effect of anti-cancer agents on the delayed hypersensitivity reaction was thought to be due to elimination of suppressor T cell activity."1.26Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon. ( Goto, M; Kitano, M; Mitsuoka, A; Sugiyama, M, 1981)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, M1
Mitsuoka, A1
Sugiyama, M1
Kitano, M1
Kondo, T1
Sakamoto, J1
Ichihashi, H1
Kamei, H1

Other Studies

2 other studies available for carbazilquinone and Delayed Hypersensitivity

ArticleYear
Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon.
    The Journal of experimental medicine, 1981, Jul-01, Volume: 154, Issue:1

    Topics: Animals; Antineoplastic Agents; Carbazilquinone; Cell Cycle; Cyclophosphamide; Humans; Hypersensitiv

1981
Effect of alternating administration of PS-K and carbazilquinone in tumor-bearing mice.
    Gan, 1981, Volume: 72, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Phytogenic; Azirines; Carbazilquinone; Hyper

1981